MedTrace Logo

Myocarditis Post Vaccination or Multi System Inflammatory Syndrome

NCT05288426 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2022-03-21

No results posted yet for this study

Summary

BNT162b2 vaccine has become one of the most prevalent vaccines against the COVID-19 and is currently the main vaccine used in Israel. Since marketing and the beginning of use of the vaccine, we and others have reported. of the development of post vaccination myocarditis.

In this study the investigators wish to explore the long term impact on 150 patients who have been diagnosed with myocarditis or multisystem inflammatory syndrome (MIS) in the year following their diagnosis of Myocarditis.

Conditions

Interventions

OTHER

No intervention

This is an observational study, with no intervention.

Sponsors & Collaborators

  • Hadassah Medical Organization

    lead OTHER

Principal Investigators

  • Dror Mevorach, MD · Hadassah Medical Organization

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2022-05-01
Completion
2025-12-01

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05288426 on ClinicalTrials.gov